Monroe, NJ, United States of America

Atif J Khan

USPTO Granted Patents = 5 

Average Co-Inventor Count = 3.7

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Bridgewater, NJ (US) (2020)
  • Monroe, NJ (US) (2018 - 2023)

Company Filing History:


Years Active: 2018-2025

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Atif J Khan: Innovator in Tumor Treatment

Introduction

Atif J Khan is a notable inventor based in Monroe, NJ (US), recognized for his contributions to the field of cancer treatment. With a total of five patents to his name, he has made significant strides in enhancing tumor sensitivity to ionizing radiation.

Latest Patents

One of his latest patents involves a combination therapy using riluzole to enhance tumor sensitivity to ionizing radiation. This method includes administering riluzole in an effective amount to sensitize tumor cells to ionizing radiation, followed by irradiating the tumor cells with a dose effective to reduce tumor cell growth. The method may also include administering one or more additional therapeutic agents to improve treatment outcomes.

Career Highlights

Atif J Khan is affiliated with Rutgers, the State University of New Jersey, where he continues to advance research in oncology. His work focuses on innovative approaches to cancer treatment, particularly in improving the efficacy of existing therapies.

Collaborations

He collaborates with esteemed colleagues such as Suzie Chen and James S Goydos, contributing to a dynamic research environment that fosters innovation in cancer therapies.

Conclusion

Atif J Khan's work exemplifies the intersection of innovation and medical research, particularly in the fight against cancer. His patents reflect a commitment to improving patient outcomes through advanced therapeutic methods.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…